Recommendations of perioperative systemic therapies considering age or comorbidities in the National Comprehensive Cancer Network (NCCN) guidelines and quality of cited evidence

IF 2 Q3 HEALTH POLICY & SERVICES
Sruthi Ranganathan , Myung Sun Kim , Timothee Olivier , Alyson Haslam , Vinay Prasad
{"title":"Recommendations of perioperative systemic therapies considering age or comorbidities in the National Comprehensive Cancer Network (NCCN) guidelines and quality of cited evidence","authors":"Sruthi Ranganathan ,&nbsp;Myung Sun Kim ,&nbsp;Timothee Olivier ,&nbsp;Alyson Haslam ,&nbsp;Vinay Prasad","doi":"10.1016/j.jcpo.2025.100600","DOIUrl":null,"url":null,"abstract":"<div><h3>Importance</h3><div>Perioperative therapy for cancer is offered to reduce the recurrence and improve overall long-term outcomes. Age and comorbidities of patients can influence the effectiveness and/or safety of perioperative therapy. It is important that key national guidelines, such as the National Comprehensive Cancer Network (NCCN) guidelines, reflect the benefit of perioperative therapy for key subpopulations of patients. However, this has not been evaluated.</div></div><div><h3>Objective</h3><div>To evaluate the perioperative treatment guidance, with regards to age and comorbidities, reported in the NCCN guidelines</div></div><div><h3>Design setting, and participants</h3><div>Cross-sectional study of NCCN recommendations regarding age and comorbidity in perioperative settings.</div></div><div><h3>Intervention</h3><div>not applicable.</div></div><div><h3>Main outcome and measure</h3><div>The existence of age or comorbidity-specific guidelines for perioperative therapy, the presence of literature support for these specific guidelines, and where they exist.</div></div><div><h3>Results</h3><div>Only 2 of the 10 cancer types studied had specific guidelines on perioperative therapy based on age, and 4 out of 10 had guidelines on perioperative therapy considering patients’ comorbidities. Half of 10 cancer guidelines (5 out of 10) and 4 out 10 had vague advice on consideration of age and comorbidities respectively. A total of 30 recommendations were made across the guidelines studied. Studies that were cited to support these recommendations were often pooled analyses of RCTs or subgroup analysis of randomized controlled trials (RCTs) (33 %).</div></div><div><h3>Conclusion and relevance</h3><div>This study shows the lack of age and comorbidity-specific guidelines for many cancer types in the NCCN guidelines. In addition, several of these recommendations, when they exist, are also not supported by strong evidence such as RCTs. There is a need for more comprehensive guidelines that make recommendations accounting for patient-intrinsic factors.</div></div>","PeriodicalId":38212,"journal":{"name":"Journal of Cancer Policy","volume":"45 ","pages":"Article 100600"},"PeriodicalIF":2.0000,"publicationDate":"2025-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cancer Policy","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S221353832500044X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEALTH POLICY & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

Importance

Perioperative therapy for cancer is offered to reduce the recurrence and improve overall long-term outcomes. Age and comorbidities of patients can influence the effectiveness and/or safety of perioperative therapy. It is important that key national guidelines, such as the National Comprehensive Cancer Network (NCCN) guidelines, reflect the benefit of perioperative therapy for key subpopulations of patients. However, this has not been evaluated.

Objective

To evaluate the perioperative treatment guidance, with regards to age and comorbidities, reported in the NCCN guidelines

Design setting, and participants

Cross-sectional study of NCCN recommendations regarding age and comorbidity in perioperative settings.

Intervention

not applicable.

Main outcome and measure

The existence of age or comorbidity-specific guidelines for perioperative therapy, the presence of literature support for these specific guidelines, and where they exist.

Results

Only 2 of the 10 cancer types studied had specific guidelines on perioperative therapy based on age, and 4 out of 10 had guidelines on perioperative therapy considering patients’ comorbidities. Half of 10 cancer guidelines (5 out of 10) and 4 out 10 had vague advice on consideration of age and comorbidities respectively. A total of 30 recommendations were made across the guidelines studied. Studies that were cited to support these recommendations were often pooled analyses of RCTs or subgroup analysis of randomized controlled trials (RCTs) (33 %).

Conclusion and relevance

This study shows the lack of age and comorbidity-specific guidelines for many cancer types in the NCCN guidelines. In addition, several of these recommendations, when they exist, are also not supported by strong evidence such as RCTs. There is a need for more comprehensive guidelines that make recommendations accounting for patient-intrinsic factors.
国家综合癌症网络(NCCN)指南中考虑年龄或合并症的围手术期全身治疗建议和引用证据的质量。
重要性:癌症围手术期治疗可减少复发,改善整体远期预后。患者的年龄和合并症会影响围手术期治疗的有效性和/或安全性。重要的是,关键的国家指南,如国家综合癌症网络(NCCN)指南,反映围手术期治疗对关键亚群患者的益处。然而,这一点尚未得到评估。目的:评估NCCN指南中关于年龄和合并症的围手术期治疗指南,参与者:NCCN围手术期治疗指南中的年龄和合并症。干预:年龄和合并症主要结果和测量:围手术期治疗是否存在针对年龄或合并症的指南,是否有文献支持这些特定指南,以及它们存在的地方。结果:研究的10种癌症类型中只有2种有基于年龄的围手术期治疗指南,4/10有考虑患者合并症的围手术期治疗指南。10份癌症指南中有5份和4份在考虑年龄和合并症方面分别有模糊的建议。在研究的指导方针中,总共提出了30项建议。被引用来支持这些建议的研究通常是随机对照试验(rct)的汇总分析或随机对照试验(rct)的亚组分析(33%)。结论和相关性:本研究显示NCCN指南中缺乏针对许多癌症类型的年龄和合并症的指南。此外,其中一些建议即使存在,也没有得到随机对照试验等强有力证据的支持。有必要制定更全面的指导方针,提出考虑到患者内在因素的建议。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Cancer Policy
Journal of Cancer Policy Medicine-Health Policy
CiteScore
2.40
自引率
7.70%
发文量
47
审稿时长
65 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信